Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
2021 · Nature · 1,586 citations
https://doi.org/10.1038/s41586-021-04389-z
J
Julian Buchrieser
Institut Pasteur(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
7.0K
Citations
30
h-index
41
i10-index
Julian Buchrieser is an academic researcher from Institut Pasteur. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & SARS-CoV-2 detection and testing. The author has an h-index of 30, co-authored 60 publications.
ORCID: 0000-0003-4790-7577Papers by this author
worksSyncytia formation by SARS‐CoV‐2‐infected cells
2020 · The EMBO Journal · 494 citations
https://doi.org/10.15252/embj.2020106267
Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells
2021 · Nature Communications · 304 citations
https://doi.org/10.1038/s41467-021-22126-y
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
2024 · Nature Communications · 223 citations
https://doi.org/10.1038/s41467-024-46490-7
IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise
2019 · Science · 160 citations
https://doi.org/10.1126/science.aaw7733
TMPRSS2 is a functional receptor for human coronavirus HKU1
2023 · Nature · 102 citations
https://doi.org/10.1038/s41586-023-06761-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat